BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus

Дата публикации: 30-09-2026 00:00:00

This case report describes 2 patients with pemphigus and off-label teclistamab use.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Melanoma Prevention Among Children of Melanoma Survivors	0	8.06	07-10-2026
2	Pseudofolliculitis Barbae Diagnosis and Treatment in US Veterans	0	8.06	30-09-2026
3	Generalized Linear Keratotic Papules in a Man in His 30s	0	6.38	30-09-2026
4	Giant Plexiform Neurofibroma in Neurofibromatosis Type 1	0	14.65	07-10-2026
5	CLIPI and Risk Stratification in Advanced Mycosis Fungoides and Sézary Syndrome	0	8.48	07-10-2026
6	Improved Risk Stratification in Mycosis Fungoides and Sézary Syndrome	0	8.93	07-10-2026
7	Bilateral Conjunctival Cysts	0	10.41	24-09-2026
8	Macular Hole Following Nd:YAG Laser Vitreolysis for Floaters	0	5.29	24-09-2026
9	MSD announces phase 2 results for tulisokibart in moderate to severe hidradenitis suppurativa	0	14.35	01-10-2026
10	Acute cholecystitis with fundal perforation: A rare but life-threatening complication	0	7.13	27-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 28.92. Источник: archderm.jamanetwork.com.